Literature DB >> 9193292

Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease.

S Ebrahim1, G D Smith.   

Abstract

OBJECTIVE: To assess the effectiveness of multiple risk factor intervention in reducing cardiovascular risk factors, total mortality, and mortality from coronary heart disease among adults.
DESIGN: Systematic review and meta-analysis of randomised controlled trials in workforces and in primary care in which subjects were randomly allocated to more than one of six interventions (stopping smoking, exercise, dietary advice, weight control, antihypertensive drugs, and cholesterol lowering drugs) and followed up for at least six months.
SUBJECTS: Adults aged 17-73 years, 903000 person years of observation were included in nine trials with clinical event outcomes and 303000 person years in five trials with risk factor outcomes alone. MAIN OUTCOME MEASURES: Changes in systolic and diastolic blood pressure, smoking rates, blood cholesterol concentrations, total mortality, and mortality from coronary heart disease.
RESULTS: Net decreases in systolic and diastolic blood pressure, smoking prevalence, and blood cholesterol were 4.2 mm Hg (SE 0.19 mm Hg), 2.7 mm Hg (0.09 mm Hg), 4.2% (0.3%), and 0.14 mmol/l (0.01 mmol/l) respectively. In the nine trials with clinical event end points the pooled odds ratios for total and coronary heart disease mortality were 0.97 (95% confidence interval 0.92 to 1.02) and 0.96 (0.88 to 1.04) respectively. Statistical heterogeneity between the studies with respect to changes in mortality and risk factors was due to trials focusing on hypertensive participants and those using considerable amounts of drug treatment, with only these trials showing significant reductions in mortality.
CONCLUSIONS: The pooled effects of multiple risk factor intervention on mortality were insignificant and a small, but potentially important, benefit of treatment (about a 10% reduction in mortality) may have been missed. Changes in risk factors were modest, were related to the amount of pharmacological treatment used, and in some cases may have been overestimated because of regression to the mean, lack of intention to treat analyses, habituation to blood pressure measurement, and use of self reports of smoking. Interventions using personal or family counselling and education with or without pharmacological treatments seem to be more effective at reducing risk factors and therefore mortality in high risk hypertensive populations. The evidence suggests that such interventions implemented through standard health education methods have limited use in the general population. Health protection through fiscal and legislative measure may be more effective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9193292      PMCID: PMC2126863          DOI: 10.1136/bmj.314.7095.1666

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  64 in total

Review 1.  The increasing necessity for market-based pharmaceutical prices.

Authors:  J E Calfee
Journal:  Pharmacoeconomics       Date:  2000       Impact factor: 4.981

2.  Five year follow up of patients at high cardiovascular risk who took part in randomised controlled trial of health promotion.

Authors:  M E Cupples; A McKnight
Journal:  BMJ       Date:  1999-09-11

3.  Health promotion activity should be retargeted at secondary prevention.

Authors:  S Ebrahim; G D Smith; R Bennett
Journal:  BMJ       Date:  2000-01-15

Review 4.  General practitioners' continuing education: a review of policies, strategies and effectiveness, and their implications for the future.

Authors:  F Smith; A Singleton; S Hilton
Journal:  Br J Gen Pract       Date:  1998-10       Impact factor: 5.386

5.  Behavioural counselling in general practice about risk of CHD. Study was grossly underpowered.

Authors:  F D Hobbs
Journal:  BMJ       Date:  2000-07-01

6.  Sickness absence and early retirement on health grounds in the construction industry in Ireland.

Authors:  H Brenner; W Ahern
Journal:  Occup Environ Med       Date:  2000-09       Impact factor: 4.402

Review 7.  Primary prevention of heart disease and stroke: a simplified approach to estimating risk of events and making drug treatment decisions.

Authors:  J P McCormack; M Levine; R E Rangno
Journal:  CMAJ       Date:  1997-08-15       Impact factor: 8.262

8.  Randomized controlled trial on the long-term efficacy of a multifaceted, interdisciplinary lifestyle intervention in reducing cardiovascular risk and improving lifestyle in patients at risk of cardiovascular disease.

Authors:  Lysanne Goyer; Robert Dufour; Caroline Janelle; Chantal Blais; Christine L'Abbé; Emilie Raymond; Jacques de Champlain; Pierre Larochelle
Journal:  J Behav Med       Date:  2012-03-09

Review 9.  The case of the missing data.

Authors:  James Le Fanu
Journal:  BMJ       Date:  2002-12-21

10.  The clinical and economic impact of a secondary heart disease prevention clinic jointly implemented by a practice nurse and pharmacist.

Authors:  Val Reilly; Margaret Cavanagh
Journal:  Pharm World Sci       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.